George Mason University employs rapid-result COVID-19 tests to control the spread of virus on campus
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific
The adjustable tip spacing pipettes from INTEGRA are used to increase efficiency in the production of venom-based screening assays
RNA controls can help avoid false negative results
Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing
The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination
Dr. Santu Saha shares his team’s groundbreaking work to develop improved cancer treatments to avoid the potential side effects of chemotherapy
The device is a high-throughput-compatible neuronal compartmentalization and co-culture microfluidic platform
New crowdsourcing project to examine the ‘Translocation of Complex Macromolecules Across the Intestinal Epithelial Barrier’
This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2
Researchers have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others
Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
Join our webinar series and roundtable discussion on Tuesday, February 2, to find out more about an innovative technology that promises to increase kinetic workflow throughput
In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
Cabenuva allows virologically suppressed adults with HIV to maintain viral suppression with 12 dosing days per year
Developed in partnership with Rosetta Biosciences, discovery enables simultaneous detection of multiple targets, furthering next generation of diagnostics
The strategic collaboration aims to accelerate clinical trials and drive critical developments for promising COVID-19 treatments
The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years
The new institute aims to meet the urgent need to do more research into the antimicrobial resistance
Panel supports research to distinguish between types of chronic inflammatory airway disease including asthma, COPD and IPF
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions
The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs
Watch this on-demand webinar to learn about the potential of computer-assisted interpretation and linking disease markers identified by NMR to the metagene database